No muscle atrophy without GSK-3β. Focus on "Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy"
- PMID: 21865590
- DOI: 10.1152/ajpcell.00310.2011
No muscle atrophy without GSK-3β. Focus on "Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy"
Comment on
-
Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.Am J Physiol Cell Physiol. 2011 Nov;301(5):C995-C1007. doi: 10.1152/ajpcell.00520.2010. Epub 2011 Aug 10. Am J Physiol Cell Physiol. 2011. PMID: 21832246
Similar articles
-
Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.Am J Physiol Cell Physiol. 2011 Nov;301(5):C995-C1007. doi: 10.1152/ajpcell.00520.2010. Epub 2011 Aug 10. Am J Physiol Cell Physiol. 2011. PMID: 21832246
-
Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle.Biochim Biophys Acta. 2015 Mar;1852(3):490-506. doi: 10.1016/j.bbadis.2014.12.006. Epub 2014 Dec 8. Biochim Biophys Acta. 2015. PMID: 25496993
-
Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.Am J Physiol Cell Physiol. 2007 May;292(5):C1636-44. doi: 10.1152/ajpcell.00504.2006. Epub 2006 Dec 13. Am J Physiol Cell Physiol. 2007. PMID: 17166938
-
Regulation of skeletal muscle plasticity by glycogen synthase kinase-3β: a potential target for the treatment of muscle wasting.Curr Pharm Des. 2013;19(18):3276-98. doi: 10.2174/1381612811319180011. Curr Pharm Des. 2013. PMID: 23151136 Review.
-
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain.J Pharmacol Sci. 2009 Feb;109(2):174-8. doi: 10.1254/jphs.08r29fm. Epub 2009 Jan 29. J Pharmacol Sci. 2009. PMID: 19179803 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources